Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Spring

Showing results (231-240 of 238) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 238 results.
Chemical Science|October 3, 2017
Protein modification <i>via</i> alkyne hydrosilylation using a substoichiometric amount of ruthenium(ii) catalystTerence T-L Kwan, Omar Boutureira, Elizabeth C Frye, et al.
Current Topics in Medicinal Chemistry|April 8, 2011
Chemogenomics approaches for receptor deorphanization and extensions of the chemogenomics concept to phenotypic spaceEelke van der Horst, Julio E Peironcely, Gerard J P van Westen, et al.
ACS Omega|January 21, 2020
Development of a Novel Cell-Permeable Protein-Protein Interaction Inhibitor for the Polo-box Domain of Polo-like Kinase 1David J Huggins, Bryn S Hardwick, Pooja Sharma, et al.
ACS Chemical Biology|February 1, 2019
Toolbox of Diverse Linkers for Navigating the Cellular Efficacy Landscape of Stapled PeptidesYuteng Wu, Amandeep Kaur, Elaine Fowler, et al.
Journal of Medicinal Chemistry|August 27, 2024
Selective Aurora A-TPX2 Interaction Inhibitors Have <i>In Vivo</i> Efficacy as Targeted Antimitotic AgentsSimon R Stockwell, Duncan E Scott, Gerhard Fischer, et al.
Chemical Science|June 7, 2021
Demonstration of the utility of DOS-derived fragment libraries for rapid hit derivatisation in a multidirectional fashionSarah L Kidd, Elaine Fowler, Till Reinhardt, et al.
EMBO Molecular Medicine|August 21, 2024
Novel immunotherapeutics against LGR5 to target multiple cancer typesHung-Chang Chen, Nico Mueller, Katherine Stott, et al.
EMBO Molecular Medicine|September 25, 2024
Publisher Correction: Novel immunotherapeutics against LGR5 to target multiple cancer typesHung-Chang Chen, Nico Mueller, Katherine Stott, et al.
Pageof 24

Showing results (231-240 of 238) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 238 results.
Chemical Science|October 3, 2017
Protein modification <i>via</i> alkyne hydrosilylation using a substoichiometric amount of ruthenium(ii) catalystTerence T-L Kwan, Omar Boutureira, Elizabeth C Frye, et al.
Current Topics in Medicinal Chemistry|April 8, 2011
Chemogenomics approaches for receptor deorphanization and extensions of the chemogenomics concept to phenotypic spaceEelke van der Horst, Julio E Peironcely, Gerard J P van Westen, et al.
ACS Omega|January 21, 2020
Development of a Novel Cell-Permeable Protein-Protein Interaction Inhibitor for the Polo-box Domain of Polo-like Kinase 1David J Huggins, Bryn S Hardwick, Pooja Sharma, et al.
ACS Chemical Biology|February 1, 2019
Toolbox of Diverse Linkers for Navigating the Cellular Efficacy Landscape of Stapled PeptidesYuteng Wu, Amandeep Kaur, Elaine Fowler, et al.
Journal of Medicinal Chemistry|August 27, 2024
Selective Aurora A-TPX2 Interaction Inhibitors Have <i>In Vivo</i> Efficacy as Targeted Antimitotic AgentsSimon R Stockwell, Duncan E Scott, Gerhard Fischer, et al.
Chemical Science|June 7, 2021
Demonstration of the utility of DOS-derived fragment libraries for rapid hit derivatisation in a multidirectional fashionSarah L Kidd, Elaine Fowler, Till Reinhardt, et al.
EMBO Molecular Medicine|August 21, 2024
Novel immunotherapeutics against LGR5 to target multiple cancer typesHung-Chang Chen, Nico Mueller, Katherine Stott, et al.
EMBO Molecular Medicine|September 25, 2024
Publisher Correction: Novel immunotherapeutics against LGR5 to target multiple cancer typesHung-Chang Chen, Nico Mueller, Katherine Stott, et al.
Pageof 24